Abstract

Background: Numerous studies have shown a relationship between low serum selenium levels and an increased risk of developing cancer. Methods: A total of 306 women participated in the study: 153 patients diagnosed with endometrial cancer and 153 healthy women who were matched, in terms of birth year (+/−3 years), to the patients from the study group. The quantitative measurement of selenium content in the collected blood samples was performed using a mass spectrometer with excitation in inductively coupled plasma. In order to determine the relationship between the risk factors and the incidence of endometrial cancer, analyses based on single- and multi-factor conditional logistic regression models were performed. Results: The mean concentration of selenium was lower in patients with endometrial cancer than in healthy controls (60.63 µg/L (0.77 µmol/L) vs. 78.74 µg/L (0.99 µmol/L), respectively). When compared in quartiles, a significant association of lower selenium concentration with the incidence of endometrial cancer was recorded. The highest OR was observed in the first and second quartiles (OR-22.0, p-value < 0.001; medium selenium level 46.95 µg/L (0.59 µmol/L), and OR-5.94; p-value < 0.001; medium selenium level 63.60 µg/L (0.80 µmol/L), respectively). Conclusion: A strong correlation between the level of selenium in the blood serum and the risk of endometrial cancer indicates that patients with low levels should be a candidate group requiring appropriate preventive examinations. Further research on a larger group of patients is required.

Highlights

  • Selenium is a trace element necessary for the proper functioning of the human body

  • Our study aimed to investigate the relationship between serum selenium concentrations and the risk of developing endometrial cancer

  • Selenium obtained in the study group was at the level of 60.63 μg/L (8.85–164.42 μg/L; 0.77μmol/L), and in the control group was at the level of 78.74 μg/L (42.85–170.76 μg/L; 0.99 μmol/L)

Read more

Summary

Introduction

Selenium is required for the formation of selenocysteine, an amino acid that is genetically encoded and is required for the formation of a range of transcribed proteins known as selenoproteins This element shows a protective function against free radicals due to its presence in active centers of antioxidant enzymes, such as glutathione peroxidase [1,2,3]. Selenium is found mainly in cereals, vegetables, seafood, meat, dairy products, and nuts [5] This element is supplied to the human body through food or dietary supplements in two forms: organic (selenomethionine and selenocysteine) and inorganic (selenites and selenates). Conclusion: A strong correlation between the level of selenium in the blood serum and the risk of endometrial cancer indicates that patients with low levels should be a candidate group requiring appropriate preventive examinations. Further research on a larger group of patients is required

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.